Risk of Major Adverse Cardiovascular Events with JAK inhibitors in Alopecia Areata, a Systematic Review

Published: 28 November 2022| Version 1 | DOI: 10.17632/685d8fmcys.1
Contributor:
Colin Kincaid

Description

Systematic review of major adverse cardiovascular events in alopecia areata patients treated with janus kinase inhibitors.

Files

Categories

Alopecia Areata, Janus Kinase

Licence